Europe — EMA
Bimzelx (Bimekizumab)
Bimzelx is a subcutaneous medication used for managing moderate to severe plaque psoriasis. This biologic therapy targets specific proteins to help reduce infla
Request sourcing
What is Bimekizumab?
Bimzelx is a subcutaneous medication used for managing moderate to severe plaque psoriasis. This biologic therapy targets specific proteins to help reduce inflammation and improve skin condition.
What is Bimekizumab used for?
Bimzelx is primarily used for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific proteins involved in the inflammatory process, helping to reduce redness, itching, and scaling associated with psoriasis. People often ask, 'What is Bimzelx used for?' and the answer is that it is designed to manage symptoms of plaque psoriasis, aiding in skin healing and reducing flare-ups.
What are the side effects of Bimekizumab?
Common effects of Bimzelx may include injection site reactions such as redness, itching, or pain. Some individuals might experience fatigue, nausea, or upper respiratory infections. These effects vary and are not experienced by everyone.
What precautions apply to Bimekizumab?
Bimzelx should be used with caution in individuals with a history of infections or allergic reactions. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Always follow the prescribed guidelines for administration and storage.
What does Bimekizumab interact with?
Bimzelx may interact with other medications, including those that affect the immune system. It is advisable to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting any new medication.



